Editorial: Non-cellular immunotherapies in pediatric malignancies

Editorial: Non-cellular immunotherapies in pediatric malignancies

Bibliographic Details
Main Authors:	Sarah Alexander, Paul Harker-Murray, Robert J. Hayashi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Immunology
Subjects:	immunotherapy cancer pediatrics antibodies checkpoint inhibition vaccines
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1379278/full

Similar Items

Non-cellular immunotherapies in pediatric central nervous system tumors
by: Sarah Rumler
Published: (2023-10-01)

Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy
by: Peter Lawrence Smith, et al.
Published: (2021-11-01)

Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse model
by: Sara Marie Ivasko, et al.
Published: (2023-01-01)

The Evolution of Cancer Immunotherapy
by: Meshaal Khan, et al.
Published: (2021-06-01)

Immune Checkpoint Inhibition in Pediatric Oncology Patients: A Single-Institution Experience
by: Natalia Wojciechowska, et al.
Published: (2024-03-01)

Insights into Modern Therapeutic Approaches in Pediatric Acute Leukemias
by: Kinga Panuciak, et al.
Published: (2022-01-01)

Will Next-Generation Immunotherapy Overcome the Intrinsic Diversity and Low Immunogenicity of Sarcomas to Improve Clinical Benefit?
by: Hui Yi Chew, et al.
Published: (2020-11-01)

Neurologic Complications of Cancer Immunotherapy
by: Aseel N. Alsalem, et al.
Published: (2023-06-01)

Immunotherapy approaches for the treatment of diffuse midline gliomas
by: Joshua D. Bernstock, et al.
Published: (2022-12-01)

Tumor immunotherapy: Mechanisms and clinical applications
by: Cheng Nong, et al.
Published: (2022-06-01)

Current Advancements and Future Perspectives of Immunotherapy in Breast Cancer Treatment
by: Maria Vasileiou, et al.
Published: (2023-05-01)

Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLC
by: Kah Yee Goh, et al.
Published: (2023-02-01)

Emerging Immunotherapy Approaches for Treating Prostate Cancer
by: Lingbin Meng, et al.
Published: (2023-09-01)

Immunotherapy in Prostate Cancer
by: Emily K. Fay, et al.
Published: (2020-07-01)

The Cellular and Molecular Immunotherapy in Prostate Cancer
by: Anirban Goutam Mukherjee, et al.
Published: (2022-08-01)

Emerging trends in immunotherapy for pediatric sarcomas
by: Kyle A. Dyson, et al.
Published: (2019-07-01)

Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy
by: Nicholas J. Bevins, et al.
Published: (2022-11-01)

Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer
by: Chenyi Luo, et al.
Published: (2022-06-01)

Editorial of special focus on melanoma immunotherapy
by: Ernesto Rossi
Published: (2022-05-01)

Potential Promises and Perils of Human Biological Treatments for Immunotherapy in Veterinary Oncology
by: Jeilene N. Hambly, et al.
Published: (2023-05-01)

Immunotherapy in Multiple Myeloma
by: Cinnie Yentia Soekojo, et al.
Published: (2020-03-01)

CELLULAR IMMUNOTHERAPY: A MODERN APPROACH TO TREATMENT OF ONCOLOGICAL DISEASES
by: Yu. N. Lezhnin, et al.
Published: (2018-06-01)

Dual-responsive nanovaccine for cytosolic delivery of antigens to boost cellular immune responses and cancer immunotherapy
by: Yang Sui, et al.
Published: (2022-07-01)

A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials
by: Siddhartha Srivastava, et al.
Published: (2019-04-01)

Editorial: Impact of immunotherapy in lung cancer
by: Marion Ferreira, et al.
Published: (2022-11-01)

Editorial: Personalized immunotherapy for cancer
by: Anna Pasetto, et al.
Published: (2023-03-01)

Case report: Patient specific combination of surgery and immunotherapy in advanced squamous cell carcinoma of the head and neck – a case series and review of literature
by: Manuel Olmos, et al.
Published: (2022-10-01)

Balancing the Risk of Adverse Events against the Efficacy of Immunotherapy in Advanced Thymic Epithelial Tumors
by: Birte Ohm, et al.
Published: (2022-12-01)

Checkpoint Immunotherapy in Pediatric Oncology: Will We Say Checkmate Soon?
by: Alexander Ciurej, et al.
Published: (2023-12-01)

Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials
by: Patrick M. McCarthy, et al.
Published: (2023-03-01)

Immunotherapy against Prion Disease
by: Yue Ma, et al.
Published: (2020-03-01)

Therapeutic Advances in Immunotherapies for Hematological Malignancies
by: Ayako Nogami, et al.
Published: (2022-09-01)

Immunotherapy Strategies for Gastrointestinal Stromal Tumor
by: Junaid Arshad, et al.
Published: (2021-07-01)

Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies
by: Rebecca Adams, et al.
Published: (2022-12-01)

Dendritic Cells and Their Role in Immunotherapy
by: Alycia Gardner, et al.
Published: (2020-05-01)

Immunotherapies and Combination Strategies for Immuno-Oncology
by: Cody Barbari, et al.
Published: (2020-07-01)

BAT6026, a novel anti-OX40 antibody with enhanced antibody dependent cellular cytotoxicity effect for cancer immunotherapy
by: Shizhong Liang, et al.
Published: (2023-07-01)

Immunotherapy in Gastric Cancer
by: Anica Högner, et al.
Published: (2022-03-01)

Ubiquitination in T-Cell Activation and Checkpoint Inhibition: New Avenues for Targeted Cancer Immunotherapy
by: Shubhangi Gavali, et al.
Published: (2021-10-01)

Antibody-based cancer immunotherapy by targeting regulatory T cells
by: Quanxiao Li, et al.
Published: (2023-04-01)